TeleTrader 7/27/2024 G20 agrees to work together to tax billionaires
GlobeNewswire 7/26/2024 Ipsen receives CHMP positive opinions for Iqirvo® (elafibranor) in Primary Biliary Cholangitis and K...
TeleTrader 7/25/2024 Nikki Haley not surprised by Biden's presidential race exit
GlobeNewswire 7/25/2024 Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondar...
GlobeNewswire 7/24/2024 Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement wi...
GlobeNewswire 7/24/2024 Tiziana Life Sciences Granted FDA Fast Track Designation
GlobeNewswire 7/23/2024 Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment...
GlobeNewswire 7/22/2024 Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an...
GlobeNewswire 7/18/2024 Alkeus Pharmaceuticals Announces Presentation of a TEASE-3 Study Update Showing Progression Stalled ...
GlobeNewswire 7/17/2024 Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multip...
GlobeNewswire 7/17/2024 Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multip...
GlobeNewswire 7/17/2024 Opthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory Board
GlobeNewswire 7/16/2024 Progressive Reports June 2024 Results
TeleTrader 7/15/2024 Syrians head to polls for parliamentary elections
GlobeNewswire 7/15/2024 Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer
TeleTrader 7/13/2024 Progressive Caucus meets with Biden
GlobeNewswire 7/11/2024 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...
TeleTrader 7/11/2024 Peskov: NATO nears Russia's borders, could provoke response
GlobeNewswire 7/9/2024 Opthea Announces Publication on VEGF-C and D Signaling Pathways as Potential Targets for Treatment o...
GlobeNewswire 7/9/2024 Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Eval...
TeleTrader 7/8/2024 Lula proud of France's fight against 'extremism'
TeleTrader 7/5/2024 Trudeau, Albanese welcome Labour Party's landslide victory
GlobeNewswire 7/3/2024 Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients...
GlobeNewswire 7/3/2024 Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
GlobeNewswire 6/25/2024 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial